Meanwhile, orforgliprons oral GLP-1 format may finally unlock mass adoption by removing injection-related barriers, while Survodutide, CT-388, and Pemvidutide demonstrate that dual and triple agonists, with novel combinations of GLP-1, glucagon, and GIP, can outperform monotherapies in both efficacy and metabolic breadth
The role of adjuvant pharmacotherapy with liraglutide for patients with inadequate weight loss following bariatric surgery
Doses increase over time to maximize appetite suppression and weight loss
5-Amino-1MQ is produced under controlled manufacturing conditions designed to promote consistency across production lots and reduce variability between batches
Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the helping evaluate exenatide in patients with diabetes compared with long-acting insulin (HEELA) study